Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.

Patel N, Penkert RR, Jones BG, Sealy RE, Surman SL, Sun Y, Tang L, DeBeauchamp J, Webb A, Richardson J, Heine R, Dallas RH, Ross AC, Webby R, Hurwitz JL.

Viruses. 2019 Sep 30;11(10). pii: E907. doi: 10.3390/v11100907.

2.

Background check: Profound differences in serum antibody isotypes among C57BL/6 mouse substrains discourage substrain interchanges in immunology experiments.

Jones BG, Penkert RR, Surman SL, Sealy RE, Pelletier S, Berns H, Hurwitz JL.

Immunol Lett. 2019 Aug 19;216:9-11. doi: 10.1016/j.imlet.2019.05.011. [Epub ahead of print] No abstract available.

PMID:
31437463
3.

Influences of Vitamin A on Vaccine Immunogenicity and Efficacy.

Penkert RR, Rowe HM, Surman SL, Sealy RE, Rosch J, Hurwitz JL.

Front Immunol. 2019 Jul 17;10:1576. doi: 10.3389/fimmu.2019.01576. eCollection 2019.

4.

Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

Sealy RE, Jones BG, Surman SL, Penkert RR, Pelletier S, Neale G, Hurwitz JL.

Vaccines (Basel). 2019 Feb 27;7(1). pii: E26. doi: 10.3390/vaccines7010026. Review.

5.

Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.

Jones BG, Sealy RE, Penkert RR, Surman SL, Maul RW, Neale G, Xu B, Gearhart PJ, Hurwitz JL.

Int Immunol. 2019 Mar 5;31(3):141-156. doi: 10.1093/intimm/dxy074.

PMID:
30407507
6.

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.

Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL.

Virology. 2017 Sep;509:60-66. doi: 10.1016/j.virol.2017.05.021. Epub 2017 Jun 9.

7.

Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

Penkert RR, Young NS, Surman SL, Sealy RE, Rosch J, Dormitzer PR, Settembre EC, Chandramouli S, Wong S, Hankins JS, Hurwitz JL.

Vaccine. 2017 Jun 22;35(29):3615-3620. doi: 10.1016/j.vaccine.2017.05.022. Epub 2017 May 26.

8.

CD4+ T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.

Sealy RE, Surman SL, Hurwitz JL.

Vaccine. 2017 May 9;35(20):2617-2621. doi: 10.1016/j.vaccine.2017.03.073. Epub 2017 Apr 11.

9.
10.

Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners.

Sealy RE, Surman SL, Vogel P, Hurwitz JL.

Int Immunol. 2016 Nov;28(11):559-564. Epub 2016 Jul 18.

11.

Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Surman SL, Penkert RR, Jones BG, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2016 Jan 6;23(3):219-27. doi: 10.1128/CVI.00739-15.

12.

Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.

Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL.

Viral Immunol. 2016 Jan-Feb;29(1):64-70. doi: 10.1089/vim.2015.0078. Epub 2015 Nov 6.

13.

Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells.

Penkert RR, Surman SL, Jones BG, Sealy RE, Vogel P, Neale G, Hurwitz JL.

Int Immunol. 2016 Mar;28(3):139-52. doi: 10.1093/intimm/dxv064. Epub 2015 Oct 27.

14.

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.

Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, Freiden P, Slobod KS, Gaur AH, Hayden RT, Allison K, Howlett N, Utech J, Allay J, Knight J, Sleep S, Meagher MM, Russell CJ, Portner A, Hurwitz JL.

Clin Vaccine Immunol. 2015 Mar;22(3):298-303. doi: 10.1128/CVI.00618-14. Epub 2014 Dec 31.

15.

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL.

Int Immunol. 2015 May;27(5):229-36. doi: 10.1093/intimm/dxu107. Epub 2014 Dec 4.

16.

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL.

Vaccine. 2014 May 30;32(26):3264-73. doi: 10.1016/j.vaccine.2014.03.088. Epub 2014 Apr 14.

17.

Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Surman SL, Jones BG, Sealy RE, Rudraraju R, Hurwitz JL.

Vaccine. 2014 May 7;32(22):2521-4. doi: 10.1016/j.vaccine.2014.03.025. Epub 2014 Mar 21.

18.

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Surman SL, Jones BG, Rudraraju R, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2014 Apr;21(4):598-601. doi: 10.1128/CVI.00757-13. Epub 2014 Feb 19.

19.

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

Rudraraju R, Jones BG, Surman SL, Sealy RE, Thomas PG, Hurwitz JL.

PLoS One. 2014 Jan 22;9(1):e86554. doi: 10.1371/journal.pone.0086554. eCollection 2014.

20.

Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Rudraraju R, Sealy RE, Surman SL, Thomas PG, Dayton BH, Hurwitz JL.

Viral Immunol. 2013 Dec;26(6):378-84. doi: 10.1089/vim.2013.0033.

21.

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.

Jones BG, Sealy RE, Zhan X, Freiden PJ, Surman SL, Blanchard JL, Hurwitz JL.

Vaccine. 2012 May 2;30(21):3188-95. doi: 10.1016/j.vaccine.2012.03.001. Epub 2012 Mar 14.

22.

Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.

Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL.

Vaccine. 2012 Jan 20;30(5):959-68. doi: 10.1016/j.vaccine.2011.11.046. Epub 2011 Nov 23. Erratum in: Vaccine. 2012 Nov 6;30(48):6955. Dosage error in article text.

23.

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

Zhan X, Martin LN, Slobod KS, Coleclough C, Lockey TD, Brown SA, Stambas J, Bonsignori M, Sealy RE, Blanchard JL, Hurwitz JL.

Vaccine. 2005 Nov 16;23(46-47):5306-20. Epub 2005 Jul 20.

PMID:
16095768
24.

HIV vaccine rationale, design and testing.

Slobod KS, Coleclough C, Bonsignori M, Brown SA, Zhan X, Surman S, Zirkel A, Jones BG, Sealy RE, Stambas J, Brown B, Lockey TD, Freiden PJ, Doherty PC, Blanchard JL, Martin LN, Hurwitz JL.

Curr HIV Res. 2005 Apr;3(2):107-12. Review.

PMID:
15853717
25.

Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one.

Hurwitz JL, Soike KF, Sangster MY, Portner A, Sealy RE, Dawson DH, Coleclough C.

Vaccine. 1997 Apr;15(5):533-40.

PMID:
9160521
26.

Supplemental Content

Loading ...
Support Center